Published in PLoS Biol on November 08, 2011
Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart. FASEB J (2013) 2.12
Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep (2012) 1.91
Identification of distinct ChAT⁺ neurons and activity-dependent control of postnatal SVZ neurogenesis. Nat Neurosci (2014) 1.57
Immunolocalization of the vesicular acetylcholine transporter in larval and adult Drosophila neurons. Neurosci Lett (2017) 1.07
Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol (2014) 1.05
Striatal cholinergic neurotransmission requires VGLUT3. J Neurosci (2014) 0.97
Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals. J Mol Cell Cardiol (2012) 0.95
SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med (2013) 0.93
Opposing regulation of dopaminergic activity and exploratory motor behavior by forebrain and brainstem cholinergic circuits. Nat Commun (2012) 0.90
BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior. Nat Commun (2013) 0.85
Elimination of the vesicular acetylcholine transporter in the forebrain causes hyperactivity and deficits in spatial memory and long-term potentiation. Proc Natl Acad Sci U S A (2012) 0.85
Drosophila melanogaster as a genetic model system to study neurotransmitter transporters. Neurochem Int (2014) 0.85
An essential role of acetylcholine-glutamate synergy at habenular synapses in nicotine dependence. Elife (2015) 0.82
Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction. PLoS One (2013) 0.81
B6eGFPChAT mice overexpressing the vesicular acetylcholine transporter exhibit spontaneous hypoactivity and enhanced exploration in novel environments. Brain Behav (2013) 0.81
The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. Mol Psychiatry (2015) 0.80
Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance. Neurochem Int (2013) 0.80
Optogenetic studies of nicotinic contributions to cholinergic signaling in the central nervous system. Rev Neurosci (2014) 0.78
Developmental adaptation of central nervous system to extremely high acetylcholine levels. PLoS One (2013) 0.78
Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease. J Neurosci (2015) 0.77
Regulation of stress-inducible phosphoprotein 1 nuclear retention by protein inhibitor of activated STAT PIAS1. Mol Cell Proteomics (2013) 0.77
Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. Neuropsychopharmacology (2014) 0.77
Co-existence of Functionally Different Vesicular Neurotransmitter Transporters. Front Synaptic Neurosci (2016) 0.76
Pulmonary inflammation is regulated by the levels of the vesicular acetylcholine transporter. PLoS One (2015) 0.75
Neurotransmission: Dissecting co-transmission in the striatum. Nat Rev Neurosci (2011) 0.75
Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndrome. Neurology (2017) 0.75
α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation. Br J Pharmacol (2015) 0.75
Nanofibrous scaffolds for the guidance of stem cell-derived neurons for auditory nerve regeneration. PLoS One (2017) 0.75
Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A (1992) 14.96
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (1996) 7.26
Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J Neurosci (2007) 5.87
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci (2007) 4.93
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov (2007) 4.83
Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci (2003) 4.50
The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction (2000) 4.48
Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci (2010) 3.47
Cholinergic interneurons control local circuit activity and cocaine conditioning. Science (2010) 3.15
The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A (2002) 2.77
Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron (2010) 2.75
Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci (2001) 2.69
In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors. Neuron (2008) 2.69
Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci (2001) 2.54
The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci (2007) 2.46
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol (2009) 2.28
A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res (1986) 2.22
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. Nat Neurosci (2007) 2.15
Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron (2011) 2.14
Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology (2010) 2.14
A rapid Percoll gradient procedure for preparation of synaptosomes. Nat Protoc (2008) 2.02
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron (2006) 1.98
Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A (1999) 1.93
Spontaneous activity of neostriatal cholinergic interneurons in vitro. J Neurosci (1999) 1.80
From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat Rev Neurosci (2011) 1.79
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U S A (2001) 1.77
Calcium-dependent and -independent release of glutamate from synaptosomes monitored by continuous fluorometry. J Neurochem (1987) 1.58
The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci (2008) 1.57
The role of acetylcholine in cocaine addiction. Neuropsychopharmacology (2007) 1.50
Transport mechanisms in acetylcholine and monoamine storage. FASEB J (2000) 1.49
Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci (2003) 1.49
Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience (2004) 1.47
On the role of hippocampal protein synthesis in the consolidation and reconsolidation of object recognition memory. Learn Mem (2007) 1.42
Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors. J Neurosci (2010) 1.41
Plastic modifications induced by object recognition memory processing. Proc Natl Acad Sci U S A (2010) 1.40
Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A (2003) 1.39
Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science (2000) 1.38
Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum. PLoS One (2011) 1.30
The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol Cell Biol (2009) 1.27
Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. J Neurosci (2011) 1.27
Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. Neuroscientist (2003) 1.21
The mechanism of intrinsic amplification of hyperpolarizations and spontaneous bursting in striatal cholinergic interneurons. Neuron (2005) 1.18
Cholinergic neuronal defect without cell loss in Huntington's disease. Hum Mol Genet (2006) 1.17
Increased sensitivity to cocaine by cholinergic cell ablation in nucleus accumbens. Proc Natl Acad Sci U S A (2001) 1.16
A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci (2010) 1.14
Acetylcholine-dopamine balance hypothesis in the striatum: an update. Geriatr Gerontol Int (2010) 1.14
Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol (2010) 1.12
Impairment of reward-related learning by cholinergic cell ablation in the striatum. Proc Natl Acad Sci U S A (2003) 1.12
Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience (1999) 1.11
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol (2006) 1.11
CaMKIIalpha interacts with M4 muscarinic receptors to control receptor and psychomotor function. EMBO J (2010) 1.11
Removal of cholinergic input to perirhinal cortex disrupts object recognition but not spatial working memory in the rat. Eur J Neurosci (2005) 1.10
Constitutive high-affinity choline transporter endocytosis is determined by a carboxyl-terminal tail dileucine motif. J Neurochem (2005) 1.07
Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study. Biol Psychiatry (2005) 1.07
Identification of brain nuclei implicated in cocaine-primed reinstatement of conditioned place preference: a behaviour dissociable from sensitization. PLoS One (2010) 1.02
Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes. J Pharmacol Exp Ther (1996) 1.02
Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors. Eur J Pharmacol (1996) 1.01
Constitutive activity of muscarinic acetylcholine receptors. J Recept Signal Transduct Res (2006) 1.01
The hemicholinium-3 sensitive high affinity choline transporter is internalized by clathrin-mediated endocytosis and is present in endosomes and synaptic vesicles. J Neurochem (2003) 1.00
Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav (2008) 1.00
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. J Neurosci (2008) 0.99
Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging. Neuropsychopharmacology (2007) 0.99
Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET. Synapse (2000) 0.97
The "ins" and "outs" of the high-affinity choline transporter CHT1. J Neurochem (2006) 0.97
Simultaneous release of glutamate and acetylcholine from single magnocellular "cholinergic" basal forebrain neurons. J Neurosci (2006) 0.96
Novel strains of mice deficient for the vesicular acetylcholine transporter: insights on transcriptional regulation and control of locomotor behavior. PLoS One (2011) 0.93
Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Eur J Pharmacol (1993) 0.89
Structural requirements for steady-state localization of the vesicular acetylcholine transporter. J Neurochem (2005) 0.87
Quantal release of acetylcholine in mice with reduced levels of the vesicular acetylcholine transporter. J Neurochem (2010) 0.86
Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors. Eur J Pharmacol (1992) 0.85
VAChT knock-down mice show normal prepulse inhibition but disrupted long-term habituation. Genes Brain Behav (2011) 0.84
A novel tool for the investigation of glutamate release from rat cerebrocortical synaptosomes: the toxin Tx3-3 from the venom of the spider Phoneutria nigriventer. Biochem J (1996) 0.83
The diverse roles of vesicular glutamate transporter 3. Handb Exp Pharmacol (2006) 0.83
A toxin from the spider Phoneutria nigriventer that blocks calcium channels coupled to exocytosis. Br J Pharmacol (1997) 0.82
Cholinergic depletion in the nucleus accumbens: effects on amphetamine response and sensorimotor gating. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.82
Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine. Eur J Pharmacol (1989) 0.81
In vivo modulation of alpha7 nicotinic receptors on striatal glutamate release induced by anatoxin-A. Neurochem Int (2010) 0.81
Effect of protein kinase C activation on the release of [3H]acetylcholine in the presence of vesamicol. J Neurochem (1997) 0.80
Vesicular acetylcholine transporter knock-down mice show sexual dimorphism on memory. Brain Res Bull (2011) 0.78
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature (2011) 6.21
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell (2005) 5.60
The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev (2011) 5.25
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron (2005) 4.78
Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci (2003) 4.50
Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci (2004) 4.44
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A (2004) 3.60
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science (2003) 3.52
Food reward in the absence of taste receptor signaling. Neuron (2008) 3.37
Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol (2007) 3.27
Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron (2004) 2.76
Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol (2002) 2.76
A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell (2008) 2.76
Physiology of the prion protein. Physiol Rev (2008) 2.65
Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science (2004) 2.64
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A (2003) 2.62
Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol (2009) 2.60
Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol (2002) 2.54
Human fMRI evidence for the neural correlates of preparatory set. Nat Neurosci (2002) 2.51
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem (2002) 2.47
Resting-state networks show dynamic functional connectivity in awake humans and anesthetized macaques. Hum Brain Mapp (2012) 2.43
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
Visually guided grasping produces fMRI activation in dorsal but not ventral stream brain areas. Exp Brain Res (2003) 2.29
Noise reduction in BOLD-based fMRI using component analysis. Neuroimage (2002) 2.28
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain (2008) 2.28
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A (2008) 2.23
The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci (2007) 2.22
Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry (2002) 2.20
Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron (2006) 2.19
Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart. FASEB J (2013) 2.12
Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci (2002) 2.10
Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron (2003) 2.03
Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci (2002) 2.01
Brain activation during script-driven imagery induced dissociative responses in PTSD: a functional magnetic resonance imaging investigation. Biol Psychiatry (2002) 2.00
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron (2006) 1.98
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A (2011) 1.98
The nature of traumatic memories: a 4-T FMRI functional connectivity analysis. Am J Psychiatry (2004) 1.95
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci (2007) 1.93
Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science (2009) 1.88
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity. Mol Pharmacol (2010) 1.86
Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells. J Neurosci (2005) 1.85
Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents. Magn Reson Med (2008) 1.85
Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci U S A (2008) 1.85
Social context-dependent singing-regulated dopamine. J Neurosci (2006) 1.84
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology (2007) 1.83
Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry (2003) 1.79
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A (2004) 1.78
Haptic study of three-dimensional objects activates extrastriate visual areas. Neuropsychologia (2002) 1.77
Dopaminergic control of sleep-wake states. J Neurosci (2006) 1.77
Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage. Stroke (2013) 1.75
Novelty responses to relational and non-relational information in the hippocampus and the parahippocampal region: a comparison based on event-related fMRI. Hippocampus (2005) 1.68
Recall of emotional states in posttraumatic stress disorder: an fMRI investigation. Biol Psychiatry (2003) 1.67
Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem (2002) 1.67
Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla. Br J Psychiatry (2004) 1.60
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem (2009) 1.60
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A (2011) 1.55
Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci U S A (2008) 1.52
Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res (2004) 1.52
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol (2002) 1.51
A sensitive PARACEST contrast agent for temperature MRI: Eu3+-DOTAM-glycine (Gly)-phenylalanine (Phe). Magn Reson Med (2008) 1.51
Resting state default-mode network connectivity in early depression using a seed region-of-interest analysis: decreased connectivity with caudate nucleus. Psychiatry Clin Neurosci (2009) 1.50
Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci (2003) 1.49
Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science (2004) 1.47
Flexible retinotopy: motion-dependent position coding in the visual cortex. Science (2003) 1.47
Cerebral areas processing swallowing and tongue movement are overlapping but distinct: a functional magnetic resonance imaging study. J Neurophysiol (2004) 1.46
A 4.0-T fMRI study of brain connectivity during word fluency in first-episode schizophrenia. Schizophr Res (2004) 1.46
PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J Neurosci (2009) 1.46
Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci (2007) 1.45
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem (2003) 1.45
Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol (2002) 1.40
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry (2012) 1.39
Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology (2005) 1.39